Factors Influencing Non-Approval of New Drugs in Europe

Factors influencing non-approval of new drugs in Europe

Filed under: drug treatment news 2010

To investigate the potential underlying factors, we analysed all marketing applications (and assessment reports) for new active substances considered for approval at the European Medicines Agency (EMA) from 2009 to 2010 (n = 68) and evaluated the …
Read more on Nature.com

Brand-name drug prices skyrocket

Filed under: drug treatment news 2010

Overall health care expenditures hit more than $ 2 trillion in 2010, more than 10 times the $ 256 billion spent in 1980, according to the Kaiser Family Foundation. Rising drug costs are one of the main culprits behind all of these problems. … As the …
Read more on MSN Money

Why are we testing newborns for pot?

Filed under: drug treatment news 2010

A 1997 meta-analysis of 32,483 mothers published in the journal Addiction also reported, “There is inadequate evidence that cannabis, at the amount typically consumed by pregnant women, causes low birth weight.” Most recently, a 2010 population-based …
Read more on Salon

FDA Panel Turns Thumbs Down on Vibativ

Filed under: drug treatment news 2010

The panel voted 13-2 in support of the drug's efficacy in treating nosocomial pneumonia when alternatives aren't available. … Theravance resubmitted its application again in June 2010 with the additional data and post-hoc analyses of mortality. Then …
Read more on MedPage Today